Kamada (KMDA) Return on Capital Employed Growth (3y) (2021 - 2026)
Kamada (KMDA) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 1,902.00 |
| 10 | Kamada | 400.64 Mn | 327.50 Mn | 19.12 Mn | 501,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 501,105.00 |
| Dec 31, 2025 | 468,965.00 |
| Sep 30, 2025 | 501,615.00 |
| Jun 30, 2025 | 581,963.00 |
| Mar 31, 2025 | 1,143.00 |
| Dec 31, 2024 | 912.00 |
| Sep 30, 2024 | 300.00 |
| Jun 30, 2024 | 142,127.00 |
| Mar 31, 2024 | -894.00 |
| Dec 31, 2023 | -1,162.00 |
| Sep 30, 2023 | -1,111.00 |
| Jun 30, 2023 | 113,119.00 |
| Mar 31, 2023 | 87,821.00 |
| Dec 31, 2022 | 102,718.00 |
| Sep 30, 2022 | 79,505.00 |
| Jun 30, 2022 | -2,303.00 |
| Mar 31, 2022 | -2,134.00 |
| Dec 31, 2021 | -1,849.00 |
| Sep 30, 2021 | -622.00 |